HC Wainwright reissued their buy rating on shares of Strata Skin Sciences, Inc. (NASDAQ:SSKN) in a report published on Friday morning. HC Wainwright currently has a $7.00 target price on the medical device company’s stock.

Several other research analysts also recently commented on the stock. ValuEngine raised shares of Strata Skin Sciences from a strong sell rating to a sell rating in a report on Friday, September 1st. Zacks Investment Research downgraded shares of Strata Skin Sciences from a hold rating to a sell rating in a report on Wednesday, August 16th.

Shares of Strata Skin Sciences (NASDAQ SSKN) traded down $0.07 during trading hours on Friday, reaching $1.14. 153,600 shares of the company’s stock traded hands, compared to its average volume of 119,153. The company has a quick ratio of 0.93, a current ratio of 1.34 and a debt-to-equity ratio of 1.85. Strata Skin Sciences has a 1 year low of $1.06 and a 1 year high of $5.40.

Strata Skin Sciences (NASDAQ:SSKN) last announced its quarterly earnings results on Thursday, August 10th. The medical device company reported ($0.52) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.71) by $0.19. Strata Skin Sciences had a negative net margin of 56.06% and a negative return on equity of 46.70%. The firm had revenue of $8.70 million during the quarter, compared to the consensus estimate of $7.98 million. equities analysts expect that Strata Skin Sciences will post -3.14 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Strata Skin Sciences, Inc. (SSKN) Given Buy Rating at HC Wainwright” was originally published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this piece on another site, it was illegally stolen and reposted in violation of international copyright and trademark law. The legal version of this piece can be viewed at https://theolympiareport.com/2017/11/11/strata-skin-sciences-inc-sskn-given-buy-rating-at-hc-wainwright.html.

About Strata Skin Sciences

STRATA Skin Sciences, Inc, formerly MELA Sciences, Inc, is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging.

Receive News & Ratings for Strata Skin Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Skin Sciences Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.